203 related articles for article (PubMed ID: 21092083)
1. Baculovirus display of single chain antibody (scFv) using a novel signal peptide.
Kitidee K; Nangola S; Gonzalez G; Boulanger P; Tayapiwatana C; Hong SS
BMC Biotechnol; 2010 Nov; 10():80. PubMed ID: 21092083
[TBL] [Abstract][Full Text] [Related]
2. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
3. Pairwise decomposition of residue interaction energies of single chain Fv with HIV-1 p17 epitope variants.
Lee VS; Tue-ngeun P; Nangola S; Kitidee K; Jitonnom J; Nimmanpipug P; Jiranusornkul S; Tayapiwatana C
Mol Immunol; 2010 Feb; 47(5):982-90. PubMed ID: 20022377
[TBL] [Abstract][Full Text] [Related]
4. Enhanced production of functional extracellular single chain variable fragment against HIV-1 matrix protein from Escherichia coli by sequential simplex optimization.
Intachai K; Singboottra P; Leksawasdi N; Kasinrerk W; Tayapiwatana C; Butr-Indr B
Prep Biochem Biotechnol; 2015; 45(1):56-68. PubMed ID: 24884357
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
Tewari D; Notkins AL; Zhou P
J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
[TBL] [Abstract][Full Text] [Related]
6. cDNA encoding a single-chain antibody to HIV p17 with cytoplasmic or nuclear retention signals inhibits HIV-1 replication.
Tewari D; Goldstein SL; Notkins AL; Zhou P
J Immunol; 1998 Sep; 161(5):2642-7. PubMed ID: 9725267
[TBL] [Abstract][Full Text] [Related]
7. Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation.
Wu Z; Alexandratos J; Ericksen B; Lubkowski J; Gallo RC; Lu W
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11587-92. PubMed ID: 15280532
[TBL] [Abstract][Full Text] [Related]
8. Baculoviral display of functional scFv and synthetic IgG-binding domains.
Mottershead DG; Alfthan K; Ojala K; Takkinen K; Oker-Blom C
Biochem Biophys Res Commun; 2000 Aug; 275(1):84-90. PubMed ID: 10944446
[TBL] [Abstract][Full Text] [Related]
9. Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells.
Shang F; Huang H; Revesz K; Chen HC; Herz R; Pinter A
J Virol; 1991 Sep; 65(9):4798-804. PubMed ID: 1714518
[TBL] [Abstract][Full Text] [Related]
10. Three antigenic regions in p17 of human immunodeficiency virus type 1 (HIV-1) revealed by mouse monoclonal antibodies and human antibodies in HIV-1 carrier sera.
Liu X; Ota A; Watanabe M; Ueda S; Saitoh A; Shinagawa H; Nakata A; Kurimura T; Wang X; Zhao Y
Microbiol Immunol; 1995; 39(10):775-85. PubMed ID: 8577268
[TBL] [Abstract][Full Text] [Related]
11. Multiparameter optimization method and enhanced production of secreted recombinant single-chain variable fragment against the HIV-1 P17 protein from Escherichia coli by fed-batch fermentation.
Paopang P; Kasinrerk W; Tayapiwatana C; Seesuriyachan P; Butr-Indr B
Prep Biochem Biotechnol; 2016; 46(3):305-12. PubMed ID: 25831436
[TBL] [Abstract][Full Text] [Related]
12. Improved scFv anti-HIV-1 p17 binding affinity guided from the theoretical calculation of pairwise decomposition energies and computational alanine scanning.
Tue-ngeun P; Kodchakorn K; Nimmanpipug P; Lawan N; Nangola S; Tayapiwatana C; Rahman NA; Zain SM; Lee VS
Biomed Res Int; 2013; 2013():713585. PubMed ID: 24308004
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
14. A unique monoclonal antibody that recognizes mature p17 of HIV-1 but not its precursor.
Saitoh A; Tanaka N; Nakata A; Ikuta K; Shinagawa H
Microbiol Immunol; 1992; 36(1):105-11. PubMed ID: 1584067
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of OKT3-induced T cell proliferation and suppression of CD147 cell surface expression in HeLa cells by scFv-M6-1B9.
Intasai N; Tragoolpua K; Pingmuang P; Khunkaewla P; Moonsom S; Kasinrerk W; Lieber A; Tayapiwatana C
Immunobiology; 2008; 214(6):410-21. PubMed ID: 19264376
[TBL] [Abstract][Full Text] [Related]
16. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide.
Ota A; Tanaka-Taya K; Ueda S
Hybridoma; 1999 Apr; 18(2):149-57. PubMed ID: 10380014
[TBL] [Abstract][Full Text] [Related]
17. Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein.
Wu X; Conway JA; Kim J; Kappes JC
J Virol; 1994 Oct; 68(10):6161-9. PubMed ID: 8083957
[TBL] [Abstract][Full Text] [Related]
18. Specific binding of baculoviruses displaying gp64 fusion proteins to mammalian cells.
Ojala K; Mottershead DG; Suokko A; Oker-Blom C
Biochem Biophys Res Commun; 2001 Jun; 284(3):777-84. PubMed ID: 11396970
[TBL] [Abstract][Full Text] [Related]
19. A simple detection method for low-affinity membrane protein interactions by baculoviral display.
Sakihama T; Sato T; Iwanari H; Kitamura T; Sakaguchi S; Kodama T; Hamakubo T
PLoS One; 2008; 3(12):e4024. PubMed ID: 19107192
[TBL] [Abstract][Full Text] [Related]
20. Expression of gag precursor protein and secretion of virus-like gag particles of HIV-2 from recombinant baculovirus-infected insect cells.
Luo L; Li Y; Kang CY
Virology; 1990 Dec; 179(2):874-80. PubMed ID: 2238477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
